OTS.at - aktuelle Inhalte in Text, Bild, Ton und Video

Norgine GmbH

Norgine schließt Übernahme von Theravia ab

Paris (OTS) - Norgine gab heute den erfolgreichen Abschluss der Übernahme von Theravia bekannt, einem internationalen Pharmaunternehmen, das sich auf Therapien für Patienten mit seltenen und schwerwiegenden Erkrankungen...

14.08.2025, 08:03:32
/
OTS0005

Norgine

Swissmedic lässt IFINWIL® (Eflornithin) für Kinder mit Hochrisiko-Neuroblastom (HRNB) zu

Uxbridge, England (OTS) - Uxbridge, England (ots/PRNewswire)

08.07.2025, 08:04:33
/
OTS0013

Norgine

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commerc

London (OTE) - Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment...

24.01.2025, 19:01:32
/
OTE0001

Norgine

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in

London (OTE) - Back to media releases

07.01.2025, 01:01:48
/
OTE0001

Norgine

Norgine Announces Appointment of New CEO Janneke van der Kamp

London (OTE) - Norgine (the "Company"), a leading European specialty pharmaceutical company, has today announced the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective from 1...

02.10.2024, 15:02:03
/
OTE0002

Norgine

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

Research Triangle Park, N.C. and Uxbridge, England (ots/PRNewswire) - Agreement pairs Norgine's commercial expertise and leading European footprint with PEDMARQSI™, the first and only approved therapy in the European...

18.03.2024, 08:01:11
/
OTE0001

Norgine

Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer

Amsterdam (ots/PRNewswire) - Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment of Saulo Martiniano as its new Chief...

11.09.2023, 09:01:21
/
OTE0001

Norgine

Norgine Announces Investment from Goldman Sachs Asset Management

Amsterdam (ots/PRNewswire) - Today, Norgine Europe B.V. ("Norgine", the "Company"), a leading European specialty pharmaceutical company, announced that the Private Equity business within Goldman Sachs Asset Management...

27.05.2022, 11:01:10
/
OTE0001

Norgine

Norgine B.V. celebrates 30 years of the bowel preparations used in colonoscopy to help prevent and diagnose gastrointestinal diseases, including colorectal cancer

Amsterdam (ots/PRNewswire) - NORGINE B.V. (Norgine), a leading European specialist pharmaceutical company, celebrates its 30th anniversary of continuous innovation in bowel preparations at the United European Gastroenterology...

05.10.2021, 12:02:48
/
OTE0001

Norgine

Norgine B.V. enters into exclusive distribution agreement for the commercialisation of PLENVU® in China with Beijing Podconley Pharmaceutical Technology & Development Co., Ltd.

Amsterdam (ots/PRNewswire) - NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and Beijing Podconley Pharmaceutical Technology & Development Co., Ltd. (Beijing Podconley), today announced...